Retzius保留与传统机器人辅助根治性前列腺切除术的前瞻性对比研究
这项多中心前瞻性研究纳入483例接受机器人辅助根治性前列腺切除术的患者,比较Retzius保留术式(282例)与传统术式(201例)的功能恢复和生活质量。结果显示Retzius保留组术后即刻尿控率更高(70.4% vs 58.1%,p=0.02),夜遗尿更少,但长期功能恢复、生活质量及肿瘤学结局无显著差异。
要点
- Retzius保留组术后即刻尿控率显著高于传统组(70.4% vs 58.1%,p=0.02)。
- 两组在长期尿控、勃起功能、生活质量及切缘阳性率方面无显著差异。
- 研究提示手术技术对结局的影响可能小于术者因素。
核心结论
- Retzius保留机器人辅助根治性前列腺切除术较传统前入路术式术后即刻尿控更好。
- 两组在长期功能恢复、生活质量及其他重要结局方面无差异。
- 结局总体相似支持手术技术本身的影响可能小于术者因素。
研究设计与样本
- 多中心前瞻性研究,纳入2017年8月至2020年4月由3位经验丰富术者完成的483例机器人辅助根治性前列腺切除术患者。
- 其中传统机器人辅助根治性前列腺切除术201例,Retzius保留机器人辅助根治性前列腺切除术282例。
- 前瞻性收集患者及医生报告数据,围手术期和五连胜(pentafecta)结局用SPSS软件分析。
- 患者报告结局包括 urinary function、erectile function 和生活质量,在基线及术后7天、1、3、6、9、12个月评估。
主要发现
- Retzius保留组即刻尿控率70.4%,传统组58.1%(p=0.02)。
- Retzius保留组夜遗尿发生率更低(p=0.011),困扰更少(p=0.009),此后无显著差异。
- 术后1周Retzius保留组生活质量更好(p=0.004)。
- 两组在其他功能结局、生活质量、围手术期参数、并发症或切缘率方面无其他差异。
- 患者和肿瘤特征相似,但传统组低危疾病更少、中危疾病更多(p<0.001),高危疾病两组相似(p=0.071)。
临床怎么用
- 对于期望术后早期尿控恢复的前列腺癌患者,可考虑Retzius保留术式。
- 长期功能结局和肿瘤学结局与传统术式相当,术式选择可结合术者经验。
- 术后早期生活质量管理可关注Retzius保留术式的潜在优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compared standard robot-assisted radical prostatectomy and Retzius-sparing robot-assisted radical prostatectomy in a multicenter study using prospective patient reported outcome measures of functional recovery and quality of life plus standard pentafecta outcomes. MATERIALS AND METHODS: Patient and physician reported data on 483 patients who underwent robot-assisted radical prostatectomy and Retzius-sparing robot-assisted radical prostatectomy from August 2017 to April 2020 by 3 experienced surgeons had been prospectively collected. Perioperative and pentafecta outcomes were analyzed using SPSS software. Patient reported outcome measures for urinary function, erectile function and quality of life were reported at baseline and at 7 days and 1, 3, 6, 9 and 12 months postoperatively. RESULTS: A total of 201 patients underwent robot-assisted radical prostatectomy and 282 had Retzius-sparing robot-assisted radical prostatectomy. Patient and tumor characteristics were similar except for fewer low risk and more intermediate risk disease in robot-assisted radical prostatectomy vs Retzius-sparing robot-assisted radical prostatectomy (p <0.001). High risk disease was similar between groups (p=0.071). Immediate urinary continence was higher in Retzius-sparing robot-assisted radical prostatectomy group (70.4% vs 58.1%, p=0.02), with less nocturnal enuresis prevalence (p=0.011) and bother (p=0.009) with no significant differences afterwards. A better quality of life (p=0.004) was reported 1 week after surgery. No other differences in functional or quality of life outcomes, perioperative parameters, complications or margin rates were found. CONCLUSIONS: Retzius-sparing robot-assisted radical prostatectomy is associated with better immediate continence than anterior robot-assisted radical prostatectomy with no differences in longer-term functional recovery, quality of life or other important outcomes. The overall similarity in outcomes between groups lends support to the view that the surgical technique matters less than the surgeon performing it.
引用
- Umari P, Eden C, Cahill D, et al. Retzius-Sparing versus Standard Robot-Assisted Radical Prostatectomy: A Comparative Prospective Study of Nearly 500 Patients. J Urol. 2020. PMID: 33086025. doi:10.1097/JU.0000000000001435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。